CYNiO successfully raised over 2 million euros in investment to enhance its innovative CO₂-based technology for isocyanate production, aiming to revolutionize the chemical industry with sustainable practices.

Target Company Overview

CYNiO, a chemistry startup, has successfully raised over 2 million euros in investment capital to scale its sustainable technology for the production of isocyanates and strategically expand its product portfolio. This innovative company is setting new standards in a traditional industry by emphasizing safety, flexibility, and future-readiness. The significant investment is made possible through a collaboration between bmp Ventures and the IBG Innovationsfonds, as well as the TGFS Technologiegründerfonds Sachsen, who will provide essential support and expertise to guide CYNiO towards market readiness.

CYNiO is revolutionizing the production of isocyanates with a unique patented CO₂-based technology that eliminates the use of highly toxic phosgene. This groundbreaking innovation allows for safe and flexible manufacturing of smaller batches of specialized isocyanates, which are vital components in a variety of products, including pharmaceuticals, adhesives, coatings, and foams. As a result, CYNiO is essential to key industries such as pharmaceuticals, agriculture, and construction, overcoming the limitations posed by the toxic and inflexible conventional production methods that have previously hindered innovation.

Industry Overview in Germany

The chemical industry in Germany is one of the largest and most advanced sectors, characterized by innovation and robust research capabilities. It plays a pivotal role within the European economy, generating substantial revenue and